COMPASS THERAPEUTICS, INC. Operating Lease, Payments
COMPASS THERAPEUTICS, INC. (CMPX) reported Operating Lease, Payments of $300.00 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-12.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2024-08-12
- COMPASS THERAPEUTICS, INC. operating lease, payments for the quarter ending 2024-06-30 was $300.00K, a 0.00% change year-over-year.
- COMPASS THERAPEUTICS, INC. operating lease, payments for the quarter ending 2024-03-31 was $300.00K, a 0.00% change year-over-year.
- COMPASS THERAPEUTICS, INC. operating lease, payments for the quarter ending 2023-12-31 was $300.00K, a 0.00% change year-over-year.
- COMPASS THERAPEUTICS, INC. operating lease, payments for the quarter ending 2023-09-30 was $300.00K, a 0.00% change year-over-year.
- COMPASS THERAPEUTICS, INC. operating lease, payments for fiscal 2023 was $1.30M, a 0.00% change from fiscal 2022.
- COMPASS THERAPEUTICS, INC. operating lease, payments for fiscal 2022 was $1.30M.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2024-06-30 | $300.00K 10-Q · filed 2024-08-12 | $700.00K 10-Q · filed 2024-08-12 | $900.00K derived: sum of 3 quarters · filed 2024-08-12 | $1.20M derived: sum of 4 quarters · filed 2024-08-12 |
| 2024-03-31 | $300.00K 10-Q · filed 2024-05-13 | $600.00K derived: sum of 2 quarters · filed 2024-05-13 | $900.00K derived: sum of 3 quarters · filed 2024-05-13 | $1.20M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $600.00K derived: sum of 2 quarters · filed 2024-03-21 | $900.00K derived: sum of 3 quarters · filed 2024-08-12 | $1.30M 10-K · filed 2024-03-21 |
| 2023-09-30 | $300.00K 10-Q · filed 2023-11-09 | $600.00K derived: sum of 2 quarters · filed 2024-08-12 | $1.00M 10-Q · filed 2023-11-09 | $1.20M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-06-30 | $300.00K 10-Q · filed 2024-08-12 | $700.00K 10-Q · filed 2024-08-12 | $900.00K derived: sum of 3 quarters · filed 2024-08-12 | $1.20M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $300.00K 10-Q · filed 2024-05-13 | $600.00K derived: sum of 2 quarters · filed 2024-05-13 | $900.00K derived: sum of 3 quarters · filed 2024-05-13 | $1.20M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $600.00K derived: sum of 2 quarters · filed 2024-03-21 | $900.00K derived: sum of 3 quarters · filed 2024-03-21 | $1.30M 10-K · filed 2024-03-21 |
| 2022-09-30 | $300.00K 10-Q · filed 2023-11-09 | $600.00K derived: sum of 2 quarters · filed 2023-11-09 | $1.00M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $300.00K 10-Q · filed 2023-08-03 | $700.00K 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | $300.00K 10-Q · filed 2023-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |